David Mahoney

Track

Insider profile

Currently holds positions in Corcept Therapeutics Inc and Adamas Pharmaceuticals Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Corcept Therapeutics Inc July 26, 2004 -
Lead Independent Chairman of the Board Adamas Pharmaceuticals Inc Sept. 11, 2019 -
Independent Director Gen Digital Inc April 10, 2003 - Dec. 19, 2019
Lead Independent Director Adamas Pharmaceuticals Inc Jan. 1, 2009 - Sept. 11, 2019
David Mahoney's trades of Corcept Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-17
S Sale
55,979 -19.3%
456.74
US$653,916 		55,979 -19.3% 456.74 US$653,916
2026-06-16 2026-06-16
PrS Proposed sale
70,368
189.36
US$4,121,080 		70,368 189.36 US$4,121,080
2025-05-20 2025-05-16
S Sale
21,544 -22.2%
176.11
US$1,915,095 		21,544 -22.2% 176.11 US$1,915,095
2025-05-20 2025-05-16
S Sale
23,829 -87.1%
74.17
US$1,767,452 		23,829 -87.1% 74.17 US$1,767,452
2025-05-16 2025-05-16
PrS Proposed sale
27,352
74.23
US$2,030,454 		27,352 74.23 US$2,030,454
2023-08-16 2023-08-14
S Sale
15,000 -1.2%
30.95
US$464,200 		15,000 -1.2% 30.95 US$464,200
2023-08-16 2023-08-14
S Sale
10,000 -47.0%
30.95
US$309,467 		10,000 -47.0% 30.95 US$309,467
2023-08-15 2023-08-14
PrS Proposed sale
10,000
30.87
US$308,700 		10,000 30.87 US$308,700
2023-08-14 2023-08-14
PrS Proposed sale
10,000
30.87
US$308,700 		10,000 30.87 US$308,700